Efficacy of an infant formula manufactured from a specific protein hydrolysate derived from whey protein isolate and concentrate produced by Société des Produits Nestlé S.A. in reducing the risk of developing atopic dermatitis

The European Commission asked EFSA to evaluate the efficacy of an infant formula, containing a specific protein hydrolysate derived from whey protein isolate and concentrate and manufactured by Société des Produits Nestlé S.A., in reducing the risk of developing atopic dermatitis in infants with a f...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:EFSA J
Main Authors: Castenmiller, Jacqueline, Hirsch‐Ernst, Karen‐Ildico, Kearney, John, Knutsen, Helle Katrine, Maciuk, Alexandre, Mangelsdorf, Inge, McArdle, Harry J, Naska, Androniki, Pelaez, Carmen, Pentieva, Kristina, Siani, Alfonso, Thies, Frank, Tsabouri, Sophia, Turck, Dominique, Vinceti, Marco, Marchelli, Rosangela, van Loveren, Henk, Dumas, Céline, Titz, Ariane, de Henauw, Stefaan
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Scientific Opinion
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8207397/
https://ncbi.nlm.nih.gov/pubmed/34140987
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2903/j.efsa.2021.6603
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados